RankingsPricing
  1. US-listed companies
  2. NORTHWEST BIOTHERAPEUTICS INC
  3. Financials
  4. Operating margin (%)

NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$364.6M
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2024-4,812.4-52.20%
Dec 31, 2018-10,068.2-38.13%
Dec 31, 2017-16,273.2+27.90%
Dec 31, 2016-12,723.3+75.21%
Dec 31, 2015-7,261.9+4.39%
Dec 31, 2014-6,956.2+426.50%
Dec 31, 2013-1,321.2+6.75%
Dec 31, 2012-1,237.6+27.94%
Dec 31, 2011-967.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)